NASDAQ:HPTX - Horizon Therapeutics Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Horizon Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume786,899 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Horizon Therapeutics, Inc, formerly Hyperion Therapeutics, Inc, is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutics to treat disorders in the areas of orphan diseases. The Company's products include RAVICTI (glycerol phenylbutyrate) oral liquid, BUPHENYL and AMMONAPS (sodium phenylbutyrate) tablets and powder. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryBiotechnology SectorN/A Current SymbolNASDAQ:HPTX Previous Symbol CUSIP44915N10 CIK1386858 WebN/A Phone+1-650-7457802Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive HPTX News and Ratings via Email Sign-up to receive the latest news and ratings for HPTX and its competitors with MarketBeat's FREE daily newsletter. Horizon Therapeutics (NASDAQ:HPTX) Frequently Asked Questions What is Horizon Therapeutics' stock symbol? Horizon Therapeutics trades on the NASDAQ under the ticker symbol "HPTX." How were Horizon Therapeutics' earnings last quarter? Horizon Therapeutics Inc (NASDAQ:HPTX) announced its quarterly earnings data on Thursday, February, 26th. The biopharmaceutical company reported $0.47 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.20) by $0.67. The biopharmaceutical company earned $30.80 million during the quarter, compared to the consensus estimate of $24.60 million. Horizon Therapeutics's quarterly revenue was up 65.6% compared to the same quarter last year. View Horizon Therapeutics' Earnings History. Has Horizon Therapeutics been receiving favorable news coverage? Media headlines about HPTX stock have been trending very negative recently, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Horizon Therapeutics earned a news impact score of -3.7 on InfoTrie's scale. They also gave news coverage about the biopharmaceutical company a news buzz of 2.0 out of 10, indicating that recent news coverage is very unlikely to have an effect on the company's share price in the immediate future. View News Stories for Horizon Therapeutics. Who are some of Horizon Therapeutics' key competitors? Some companies that are related to Horizon Therapeutics include Amgen (AMGN), Gilead Sciences (GILD), Celgene (CELG), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Regeneron Pharmaceuticals (REGN), Alexion Pharmaceuticals (ALXN), Seattle Genetics (SGEN), Incyte (INCY), BioMarin Pharmaceutical (BMRN), Alnylam Pharmaceuticals (ALNY), EXACT Sciences (EXAS), Neurocrine Biosciences (NBIX), Ionis Pharmaceuticals (IONS) and Exelixis (EXEL). What other stocks do shareholders of Horizon Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Horizon Therapeutics investors own include Tivity Health (TVTY), Cognex (CGNX), Cynosure (CYNO), Depomed (DEPO), Infinity Pharmaceuticals (INFI), Keryx Biopharmaceuticals (KERX), Questcor Pharmaceuticals (QCOR), TG Therapeutics (TGTX), Wright Medical Group (WMGI) and Bausch Health Companies (BHC). How can I contact Horizon Therapeutics? Horizon Therapeutics' mailing address is 2000 Sierra Point Pkwy Ste 400, BRISBANE, CA 94005-1849, United States. The biopharmaceutical company can be reached via phone at +1-650-7457802. MarketBeat Community Rating for Horizon Therapeutics (NASDAQ HPTX)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 163 (Vote Outperform)Underperform Votes: 116 (Vote Underperform)Total Votes: 279MarketBeat's community ratings are surveys of what our community members think about Horizon Therapeutics and other stocks. Vote "Outperform" if you believe HPTX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HPTX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/25/2020 by MarketBeat.com StaffFeatured Article: What do I need to know about analyst ratings?